A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer Meeting Abstract


Authors: O'Reilly, E.; Hammond, L.; Donehower, R.; Schwartz, G.; Kelvin, J.; Aird, S.; Sharma, S.; Schrag, D.; Molloy, K.; De Jager, R.
Abstract Title: A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer
Meeting Title: 25th European Society of Medical Oncology (ESMO) Congress
Journal Title: Annals of Oncology
Volume: 11
Issue: Suppl. 4
Meeting Dates: 2000 Oct 13-17
Meeting Location: Hamburg, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2000-01-01
Start Page: 63
Language: English
ACCESSION: WOS:000089503900278
PROVIDER: wos
PUBMED: 11077566
DOI: 10.1093/annonc/11.suppl_4.62
Notes: Meeting Abstract: 277O -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. Sunil Sharma
    26 Sharma
  3. Deborah Schrag
    199 Schrag
  4. Eileen O'Reilly
    686 O'Reilly
  5. Joanne F Kelvin
    91 Kelvin
  6. Suzan M Aird
    3 Aird